These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19969320)

  • 21. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
    Durbin AP; McAuliffe JM; Collins PL; Murphy BR
    Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant.
    Briggs CM; Holder RC; Reid SD; Parks GD
    Microbes Infect; 2011 Apr; 13(4):359-68. PubMed ID: 21185944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates.
    Bartlett EJ; Cruz AM; Boonyaratanakornkit J; Esker J; Castaño A; Skiadopoulos MH; Collins PL; Murphy BR; Schmidt AC
    Vaccine; 2010 Jan; 28(3):767-79. PubMed ID: 19857454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.
    Ohta K; Matsumoto Y; Yumine N; Nishio M
    Virology; 2018 Nov; 524():90-96. PubMed ID: 30165310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human parainfluenza virus type 2 V protein inhibits induction of tetherin.
    Ohta K; Matsumoto Y; Yumine N; Nishio M
    Med Microbiol Immunol; 2017 Aug; 206(4):311-318. PubMed ID: 28455649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection.
    Durbin AP; Elkins WR; Murphy BR
    Vaccine; 2000 May; 18(22):2462-9. PubMed ID: 10738104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological association of inducible bronchus-associated lymphoid tissue organogenesis in Ag85B-rHPIV2 vaccine-induced anti-tuberculosis mucosal immune responses in mice.
    Nagatake T; Suzuki H; Hirata SI; Matsumoto N; Wada Y; Morimoto S; Nasu A; Shimojou M; Kawano M; Ogami K; Tsujimura Y; Kuroda E; Iijima N; Hosomi K; Ishii KJ; Nosaka T; Yasutomi Y; Kunisawa J
    Int Immunol; 2018 Sep; 30(10):471-481. PubMed ID: 30011025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.
    Mayer AE; Johnson JB; Parks GD
    Virology; 2014 Jul; 460-461():23-33. PubMed ID: 25010267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication.
    Parisien JP; Lau JF; Horvath CM
    J Virol; 2002 Jul; 76(13):6435-41. PubMed ID: 12050355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.
    Parisien JP; Lau JF; Rodriguez JJ; Sullivan BM; Moscona A; Parks GD; Lamb RA; Horvath CM
    Virology; 2001 May; 283(2):230-9. PubMed ID: 11336548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.
    Bartlett EJ; Hennessey M; Skiadopoulos MH; Schmidt AC; Collins PL; Murphy BR; Pickles RJ
    J Virol; 2008 Aug; 82(16):8059-70. PubMed ID: 18524813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization.
    Watanabe K; Matsubara A; Kawano M; Mizuno S; Okamura T; Tsujimura Y; Inada H; Nosaka T; Matsuo K; Yasutomi Y
    Vaccine; 2014 Mar; 32(15):1727-35. PubMed ID: 24486310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Qi H; Chu V; Wu NC; Chen Z; Truong S; Brar G; Su SY; Du Y; Arumugaswami V; Olson CA; Chen SH; Lin CY; Wu TT; Sun R
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2018-2023. PubMed ID: 28159892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.
    Nishio M; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y
    J Virol; 2001 Oct; 75(19):9165-76. PubMed ID: 11533180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
    Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
    J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Point Mutation in the RNA-Binding Domain of Human Parainfluenza Virus Type 2 Nucleoprotein Elicits Abnormally Enhanced Polymerase Activity.
    Matsumoto Y; Ohta K; Kolakofsky D; Nishio M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
    Xue M; Wang R; Harder O; Chen P; Lu M; Cai H; Li A; Liang X; Jennings R; La Perle K; Niewiesk S; Peeples ME; Li J
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of human parainfluenza virus 4 nucleocapsid-like particles in yeast and their use for detection of virus-specific antibodies in human serum.
    Bulavaitė A; Lasickienė R; Tamošiūnas PL; Simanavičius M; Sasnauskas K; Žvirblienė A
    Appl Microbiol Biotechnol; 2017 Apr; 101(7):2991-3004. PubMed ID: 28102432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function.
    Arimilli S; Alexander-Miller MA; Parks GD
    J Virol; 2006 Apr; 80(7):3416-27. PubMed ID: 16537609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.